Brief: Cardiol Announces Positive Study Results Showing Cardioprotective Effects Of Subcutaneously Administered Cannabidiol
10/10/2023 13:04
Oct 10 (Reuters) - Cardiol Therapeutics Inc CRDL.TO :
* CARDIOL - ANNOUNCES POSITIVE STUDY RESULTS SHOWING
CARDIOPROTECTIVE EFFECTS OF SUBCUTANEOUSLY ADMINISTERED
CANNABIDIOL
Further company coverage: CRDL.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiol Therapeutics
See all newsBrief: Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy
Brief: Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus
Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis
NASDAQ RESUMED AT 09:00 AM